Garlich; Joseph R.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Garlich; Joseph R..The latest application filed is for "single molecule compounds providing multi-target inhibition of btk and other proteins and methods of use thereof".
Company Profile
3.24.19
- Garlich; Joseph R. - Cape Coral FL
- GARLICH; Joseph R. - Fort Collins CO
- Garlich; Joseph R. - Volcano HI
- Garlich; Joseph R. - Hawaii National Park HI
- Garlich; Joseph R. - Westfield IN US
- Garlich; Joseph R. - Lake Jackson TX
Patent Activity
| Patent | Date |
|---|---|
| Single Molecule Compounds Providing Multi-Target Inhibition of BTK and Other Proteins and Methods of Use Thereof App 20210300939 - Morales; Guillermo A. ; et al. | 2021-09-30 |
| Thienopyranones and Furanopyranones as Checkpoint Inhibitors and Modulators of Anti-Tumor Immunity App 20200181164 - MORALES; Guillermo A. ; et al. | 2020-06-11 |
| Thienopyranones and Furanopyranones as Kinase, Bromodomain, and Checkpoint Inhibitors App 20190367530 - Morales; Guillermo A. ; et al. | 2019-12-05 |
| Thienopyranones as kinase and epigenetic inhibitors Grant 10,308,662 - Durden , et al. | 2019-06-04 |
| Heterocyclic compound classes for signaling modulation Grant 10,174,032 - Morales , et al. J | 2019-01-08 |
| Thienopyranones as kinase inhibitors Grant 9,981,983 - Morales , et al. May 29, 2 | 2018-05-29 |
| Thienopyranones as Kinase and Epigenetic Inhibitors App 20170334925 - Durden; Donald L. ; et al. | 2017-11-23 |
| Thienopyranones as Kinase and Epigenetic Inhibitors App 20170101418 - Durden; Donald L. ; et al. | 2017-04-13 |
| Thienopyranones as Kinase Inhibitors App 20170101419 - Morales; Guillermo A. ; et al. | 2017-04-13 |
| Thienopyranones as kinase inhibitors Grant 9,550,790 - Morales , et al. January 24, 2 | 2017-01-24 |
| Thienopyranones as kinase and epigenetic inhibitors Grant 9,505,780 - Durden , et al. November 29, 2 | 2016-11-29 |
| Thienopyranones as Kinase and Epigenetic Inhibitors App 20150344494 - Durden; Donald L. ; et al. | 2015-12-03 |
| Novel Heterocyclic Compound Classes for Signaling Modulation App 20150315207 - Morales; Guillermo A ; et al. | 2015-11-05 |
| Thienopyranones as Kinase Inhibitors App 20140073584 - Morales; Guillermo A. ; et al. | 2014-03-13 |
| Thienopyranones as kinase inhibitors Grant 8,557,807 - Morales , et al. October 15, 2 | 2013-10-15 |
| Thienopyranones As Kinase Inhibitors App 20100310466 - Morales; Guillermo A. ; et al. | 2010-12-09 |
| PI-3 kinase inhibitor prodrugs Grant 7,662,977 - Garlich , et al. February 16, 2 | 2010-02-16 |
| Targeted Bone Marrow Protection Agents App 20090011975 - Garlich; Joseph R. ; et al. | 2009-01-08 |
| Bone Targeting Of Degradable Drug Filled Nanoparticles App 20080292714 - Garlich; Joseph R. ; et al. | 2008-11-27 |
| Pi-3 Kinase Inhibitor Prodrugs App 20080188423 - Garlich; Joseph R. ; et al. | 2008-08-07 |
| PI-3 kinase inhibitor prodrugs Grant 7,396,828 - Garlich , et al. July 8, 2 | 2008-07-08 |
| Pten Inhibitors App 20070203098 - Garlich; Joseph R. ; et al. | 2007-08-30 |
| Chelate based scaffolds in tumor targeting App 20070104645 - Garlich; Joseph R. ; et al. | 2007-05-10 |
| PI-3 kinase inhibitor prodrugs Grant 6,949,537 - Garlich , et al. September 27, 2 | 2005-09-27 |
| PI-3 kinase inhibitor prodrugs App 20050203173 - Garlich, Joseph R. ; et al. | 2005-09-15 |
| PI-3 kinase inhibitor prodrugs App 20040242631 - Garlich, Joseph R. ; et al. | 2004-12-02 |
| Targeted bone marrow protection agents App 20040198783 - Garlich, Joseph R. ; et al. | 2004-10-07 |
| Frozen radiopharmaceutical formulations Grant 5,762,907 - Simon , et al. * June 9, 1 | 1998-06-09 |
| Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents Grant 5,756,065 - Wilson , et al. May 26, 1 | 1998-05-26 |
| Bicyclopolyazamacrocyclophosphonic acid half esters Grant 5,750,660 - Kiefer , et al. May 12, 1 | 1998-05-12 |
| Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents Grant 5,739,294 - Kiefer , et al. April 14, 1 | 1998-04-14 |
| Macrocyclic ligands and complexes Grant 5,652,361 - Simon , et al. July 29, 1 | 1997-07-29 |
| Macrocyclic congugates and their use as diagnostic and therapeutic agents Grant 5,435,990 - Cheng , et al. July 25, 1 | 1995-07-25 |
| Complexes possessing ortho ligating functionality Grant 5,342,604 - Wilson , et al. August 30, 1 | 1994-08-30 |
| Oral compositions for inhibiting plaque formation Grant 5,320,829 - Garlich , et al. June 14, 1 | 1994-06-14 |
| Oral compositions for suppressing mouth odors Grant 5,286,479 - Garlich , et al. February 15, 1 | 1994-02-15 |
| Macrocyclic aminophosphonic acid complexes, their formulations and use Grant 5,064,633 - Simon , et al. * November 12, 1 | 1991-11-12 |
| Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors Grant 5,059,412 - Simon , et al. * October 22, 1 | 1991-10-22 |
| Bone marrow suppressing agents Grant 4,976,950 - Simon , et al. * December 11, 1 | 1990-12-11 |
| Method for purifying aminomethylenephosphonic acids for pharmaceutical use Grant 4,937,333 - Garlich , et al. June 26, 1 | 1990-06-26 |
| Bone marrow suppressing agents Grant 4,882,142 - Simon , et al. November 21, 1 | 1989-11-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 